Total Payments
$1,125
2024 Payments
$473.84
Companies
12
Transactions
45
Medicare Patients
12,233
Medicare Billing
$944,326
Payment Breakdown by Category
Food & Beverage$1,125 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,125 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glaukos Corporation | $307.31 | 1 | $0 (2024) |
| ABBVIE INC. | $252.41 | 19 | $0 (2024) |
| Horizon Therapeutics plc | $127.51 | 8 | $0 (2023) |
| Aerie Pharmaceuticals, Inc. | $98.47 | 1 | $0 (2020) |
| Alcon Vision LLC | $83.22 | 4 | $0 (2024) |
| Amgen Inc. | $63.31 | 4 | $0 (2024) |
| Allergan, Inc. | $52.04 | 3 | $0 (2021) |
| Alcon Laboratories Inc | $42.80 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $35.93 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $32.96 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $473.84 | 10 | Glaukos Corporation ($307.31) |
| 2023 | $338.42 | 23 | ABBVIE INC. ($134.38) |
| 2022 | $119.05 | 7 | ABBVIE INC. ($60.47) |
| 2021 | $17.10 | 1 | Allergan, Inc. ($17.10) |
| 2020 | $98.47 | 1 | Aerie Pharmaceuticals, Inc. ($98.47) |
| 2018 | $12.91 | 1 | Allergan Inc. ($12.91) |
| 2017 | $64.83 | 2 | Alcon Laboratories Inc ($42.80) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: EYE CARE | ||||||
| 11/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: EYE CARE | ||||||
| 06/27/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Ophthalmology | ||||||
| 04/25/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/29/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: EYE CARE | ||||||
| 03/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/29/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Ophthalmology | ||||||
| 02/27/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/24/2024 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $307.31 | General |
| 01/24/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/22/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: TEPEZZA | ||||||
| 11/17/2023 | ABBVIE INC. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: EYE CARE | ||||||
| 10/10/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $35.93 | General |
| 10/10/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: TEPEZZA | ||||||
| 09/28/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Ophthalmology | ||||||
| 09/21/2023 | ABBVIE INC. | ALPHAGAN P (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: EYE CARE | ||||||
| 08/30/2023 | ABBVIE INC. | ALPHAGAN P (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: EYE CARE | ||||||
| 08/22/2023 | Rayner Intraocular Lenses Limited | Omidria (Drug), RayOne EMV, RayOne Spheric | Food and Beverage | Cash or cash equivalent | $15.17 | General |
| Category: Ophthalmology | ||||||
| 07/27/2023 | ABBVIE INC. | ALPHAGAN P (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: EYE CARE | ||||||
| 07/25/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: TEPEZZA | ||||||
| 06/30/2023 | ABBVIE INC. | ALPHAGAN P (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: EYE CARE | ||||||
| 06/16/2023 | ABBVIE INC. | ALPHAGAN P (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: EYE CARE | ||||||
| 05/02/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: EYE CARE | ||||||
| 04/28/2023 | ABBVIE INC. | LUMIGAN (Drug), VUITY, ALPHAGAN P | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: EYE CARE | ||||||
| 04/27/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 3,031 | 3,413 | $839,953 | $225,091 |
| 2022 | 15 | 3,100 | 3,479 | $865,123 | $230,067 |
| 2021 | 19 | 3,342 | 3,835 | $996,235 | $268,759 |
| 2020 | 17 | 2,760 | 3,129 | $847,370 | $220,409 |
Total Patients
12,233
Total Services
13,856
Medicare Billing
$944,326
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,154 | 1,283 | $421,234 | $111,334 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 428 | 571 | $133,213 | $34,960 | 26.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 379 | 392 | $63,950 | $17,359 | 27.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 162 | 183 | $42,775 | $11,693 | 27.3% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 36 | 40 | $35,069 | $10,869 | 31.0% |
| 92134 | Imaging of retina | Office | 2023 | 237 | 251 | $26,362 | $7,639 | 29.0% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 29 | 52 | $27,634 | $7,595 | 27.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 284 | 287 | $27,372 | $7,466 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 79 | $26,076 | $7,290 | 28.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 43 | 43 | $16,690 | $3,636 | 21.8% |
| 92250 | Photography of the retina | Office | 2023 | 86 | 87 | $8,444 | $2,238 | 26.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 35 | $5,124 | $1,363 | 26.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 37 | 43 | $3,082 | $832.50 | 27.0% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 17 | 35 | $1,982 | $567.94 | 28.7% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 31 | 32 | $946.48 | $248.44 | 26.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,203 | 1,304 | $434,006 | $112,373 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 442 | 610 | $144,906 | $39,267 | 27.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 338 | 342 | $56,618 | $15,447 | 27.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 164 | 181 | $42,568 | $11,857 | 27.9% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 35 | 38 | $34,109 | $10,343 | 30.3% |
| 92134 | Imaging of retina | Office | 2022 | 261 | 293 | $31,272 | $8,958 | 28.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 303 | 308 | $29,839 | $8,246 | 27.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 79 | 79 | $31,087 | $7,425 | 23.9% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 22 | 43 | $23,770 | $6,391 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 48 | $16,072 | $4,134 | 25.7% |
About Dr. Thomas Lang, MD
Dr. Thomas Lang, MD is a Ophthalmology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891772620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Lang, MD has received a total of $1,125 in payments from pharmaceutical and medical device companies, with $473.84 received in 2024. These payments were reported across 45 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,125).
As a Medicare-enrolled provider, Lang has provided services to 12,233 Medicare beneficiaries, totaling 13,856 services with total Medicare billing of $944,326. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Providence, RI
- Active Since 12/22/2005
- Last Updated 05/03/2012
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1891772620
Products in Payments
- LUMIGAN (Drug) $151.38
- TEPEZZA (Drug) $127.51
- rhopressa (Drug) $98.47
- Rocklatan (Drug) $68.88
- TEPEZZA (Biological) $63.31
- ALPHAGAN P (Drug) $53.99
- ReSTOR (Device) $42.80
- XIIDRA (Drug) $32.96
- VUITY (Drug) $29.09
- COMBIGAN (Drug) $22.03
- RESTASIS MULTIDOSE (Drug) $20.13
- Omidria (Drug) $15.17
- OZURDEX (Drug) $14.92
- Simbrinza (Drug) $14.34
- PROLENSA (Drug) $13.49
- RESTASIS (Drug) $12.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Providence
Dr. Sarah Anis, Md, MD
Ophthalmology — Payments: $178,845
Ophthalmology $178,845
Jesse Richman, Md, MD
Ophthalmology — Payments: $23,347
Ophthalmology $23,347
Dr. Yoash Enzer, M.d, M.D
Ophthalmology — Payments: $10,514
Ophthalmology $10,514
Michael Migliori, Md, MD
Ophthalmology — Payments: $6,439
Ophthalmology $6,439
Dr. Jane Cook, M.d, M.D
Ophthalmology — Payments: $3,539
Ophthalmology $3,539
King To, M.d, M.D
Ophthalmology — Payments: $3,351
Ophthalmology $3,351